Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
Mebias Discovery holds a game-changing platform to discover next generation.
Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
NeuralGalaxy is a brain science company which is devoted to solve brain disorders.
Regenacy Pharmaceuticals Provides Healthcare Services.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Cantai Therapeutics operates as a developer of drug candidates.
Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
CorneaSense is a medtech startup developing a non-invasive eye sensor to measure ocular hydration for early disease detection.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Tetris Therapeutics is a platform-based biotechnology company
BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, LB Pharmaceuticals received $150.0M in a Post-IPO Equity round. BioVenture's total known invested capital is $1.0B.
BioVenture's average investment size is $20.1M across its portfolio of 274 companies.
Recent BioVenture portfolio additions include Navrogen, Rapafusyn Pharmaceuticals, Renovacor, Nionyx Bio, Mebias Discovery. These companies were founded in 2020 or later.